Cargando…

Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma

High-dose methotrexate-based chemotherapy has extended survival in patients with primary central nervous system lymphoma (PCNSL). However, although salvage treatment is necessary in recurrent and refractory PCNSL, this has not been standardized. We herein describe the efficacy of a combination of ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Mineko, Fujimaki, Takamitsu, Asano, Shuichiro, Nakaguchi, Hiroshi, Yamada, Shoko M., Hoya, Katsumi, Yamazaki, Kazuto, Ishida, Yasuo, Matsuno, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220260/ https://www.ncbi.nlm.nih.gov/pubmed/22028172 http://dx.doi.org/10.3349/ymj.2011.52.6.1031

Ejemplares similares

Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report
por: Yamada, So, et al.
Publicado: (2012)

Radiation-induced meningiomas in multiple regions, showing rapid recurrence and a high MIB 1 labeling index: a case report and review of the literature
por: Goto, Yoshiaki, et al.
Publicado: (2014)

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma
por: Fujimaki, Takamitsu, et al.
Publicado: (2007)

Skull base osteosarcoma presenting with cerebrospinal fluid leakage after CyberKnife(®) treatment: a case report
por: Yamada, Shoko Merrit, et al.
Publicado: (2013)

Endoscopic Extracapsular Removal of Pituitary Adenoma: The Importance of Pretreatment of an Adjacent Unruptured Internal Carotid Artery Aneurysm
por: Yamada, So, et al.
Publicado: (2012)

Molecular Morphology of Pituitary Cells, from Conventional Immunohistochemistry to Fluorescein Imaging
por: Matsuno, Akira, et al.
Publicado: (2011)

Matsuno, A., et al., Molecular Morphology of Pituitary Cells, from Conventional Immunohistochemistry to Fluorescence Imaging. Molecules 2011, 16, 3618-3635
por: Matsuno, Akira, et al.
Publicado: (2012)

Clinicopathological and Molecular Histochemical Review of Skull Base Metastasis from Differentiated Thyroid Carcinoma
por: Matsuno, Akira, et al.
Publicado: (2013)

Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
por: Batara, Julette Marie F, et al.
Publicado: (2022)

Subarachnoid hemorrhage secondary to a ruptured middle cerebral aneurysm in a patient with osteogenesis imperfecta: a case report
por: Hirohata, Toshio, et al.
Publicado: (2014)

Temozolomide and cisplatin in relapsed/refractory acute leukemia
por: Seiter, Karen, et al.
Publicado: (2009)

Lemierre Syndrome Associated with Ipsilateral Recurrent Laryngeal Nerve Palsy: A Case Report and Review
por: Miyamoto, Shinya, et al.
Publicado: (2016)

High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China
por: Chen, Cui, et al.
Publicado: (2019)

Rituximab for refractory granulomatous eye disease
por: Lower, Elyse E, et al.
Publicado: (2012)

Utilization of Rituximab for Refractory Rowell Syndrome
por: Singh, Sukhraj, et al.
Publicado: (2021)

Extended-schedule dose-dense temozolomide in refractory gliomas
por: Berrocal, A., et al.
Publicado: (2009)

Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
por: Zhu, Jia, et al.
Publicado: (2022)

Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma
por: Yamamoto, Yoshinari, et al.
Publicado: (2015)

Rituximab in refractory Vogt–Koyanagi–Harada disease
por: Dolz-Marco, Rosa, et al.
Publicado: (2011)

Refractory Sweet's syndrome successfully treated with rituximab
por: Seminario-Vidal, Lucia, et al.
Publicado: (2015)

Ibrutinib for rituximab-refractory Waldenström macro-globulinemia
por: Gavriatopoulou, Maria, et al.
Publicado: (2017)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

Rituximab as an Alternative Treatment for Refractory Granulomatous Hypophysitis
por: Nokhbehzaeim, Mahrokh, et al.
Publicado: (2021)

Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021)

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Rituximab in refractory sarcoidosis: a single centre experience
por: Cinetto, Francesco, et al.
Publicado: (2015)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Rituximab: a novel treatment for refractory Riedel’s thyroiditis
por: Hunt, Leanne, et al.
Publicado: (2018)

How I treat rituximab refractory patients with WM
por: Gavriatopoulou, Maria, et al.
Publicado: (2018)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists
por: Tang, Hao, et al.
Publicado: (2021)

Primary uterine diffuse large B-cell lymphoma involving the urinary bladder with urinary cytology mimicking carcinomas: A case report
por: Adachi, Sumiyo, et al.
Publicado: (2015)

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS
por: Nagle, Sarah J, et al.
Publicado: (2017)

The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
por: Van Dijck, Ruben, et al.
Publicado: (2021)

Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders
por: Patil, Varsha A., et al.
Publicado: (2021)

Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare
por: Ribeiro, Emmanuel, et al.
Publicado: (2009)

Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011)

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
por: Bonilla-Abadía, Fabio, et al.
Publicado: (2014)

Remission Achieved in Refractory Advanced Takayasu Arteritis Using Rituximab
por: Ernst, D., et al.
Publicado: (2012)

Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
por: Lamar, Zanetta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5g2o3f0qm6f514pfouki4jfuu4